Company Directory > CRO > Avant Santé Research Center S.A. de C.V.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Avant Santé Research Center S.A. de C.V. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Avant Santé is a patient-centric Contract Research Organization (CRO) headquartered in Monterrey, Mexico, with additional operations in the USA, Colombia, Singapore, and India. The company provides integrated clinical development services, including early-phase (Phase I) and late-phase (Phase II-IV) research, bioanalytical services, pharmacovigilance, and regulatory consulting. They maintain a strong focus on metabolic and liver health, including NASH, cirrhosis, obesity, and diabetes. Avant Santé partners with global pharmaceutical and biotech sponsors to streamline drug development, leveraging Mexico's regulatory environment (COFEPRIS) to accelerate clinical trial execution and patient recruitment.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Research Organization
SIZE & FINANCIALS
Employees:100-249
Founded:2011
Ownership:private
Status:operating
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, Biologics
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Avant Sante India Private Limited
Key Partnerships:Perspectum (Strategic partnership for quantitative imaging in metabolic/liver research)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Dr. Sitaramaraju Yarramraju - CEO and Founder
Kim Ruela - VP Clinical Operations
Scientific Founders:Dr. Sitaramaraju Yarramraju
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Avant Santé Research Center S.A. de C.V.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.